PlainPharmaWatch

CMS Open Payments · Tool

Haemonetics Corporation vs Axonics, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Haemonetics Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,247, versus 767 for the other company. Its single largest recorded recipient represents 0.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Haemonetics Corporation
HHI 2,247 · top recipient 0.3%
Ranked #708 of 1,838 companies by HHI
Axonics, Inc.
HHI 767 · top recipient 0.3%
Ranked #1,139 of 1,838 companies by HHI

Payment Overview

Total Payments
$3.7M
% of Industry
0.0%
Transactions
2,104
Avg per Transaction
$1.8K
Recipients
1,963
Avg per Recipient
$1.9K
Payment Types
9
Top Payment Type
Acquisitions
Company B

Axonics, Inc.

Total Payments
$3.7M
% of Industry
0.0%
Transactions
21,364
Avg per Transaction
$174.18
Recipients
21,250
Avg per Recipient
$175.12
Payment Types
7
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Haemonetics Corporation vs Axonics, Inc. - total reported payments in CMS Open Payments PY2024

Haemonetics Corporation$3.7MAxonics, Inc.$3.7M

Payment Types Breakdown

Haemonetics Corporation

Acquisitions $612.8K

16.4%

Consulting Fee $432.7K

11.6%

Food and Beverage $87.9K

2.4%

Travel and Lodging $47.4K

1.3%

Space Rental or Facility Fees $20.4K

0.5%

Long-Term Medical Supply or Device Loan $5.9K

0.2%

Axonics, Inc.

Consulting Fee $1.4M

38.1%

Food and Beverage $839.5K

22.6%

Travel and Lodging $614.0K

16.5%

Grant $109.9K

3.0%

Space Rental or Facility Fees $14.9K

0.4%

Education $3.0K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Haemonetics Corporation

  1. 1

    MARK METZL

    $358,019.67 · 6 txns

  2. 2

    JASON ZAGRODZKY

    $330,443.24 · 3 txns

  3. 3

    CLAIRE POMEROY

    $304,477.42 · 72 txns

  4. 4

    KESHAV DESHPANDE

    $18,924.05 · 8 txns

  5. 5

    BRIAN CHO

    $15,755.71 · 11 txns

Axonics, Inc.

  1. 1

    NANCY SNYDERMAN

    $785,133.30 · 7 txns

  2. 2

    ESTEBAN LOPEZ

    $236,958.00 · 7 txns

  3. 3

    CHARLES BUTRICK

    $65,785.25 · 3 txns

  4. 4

    BRENT PARNELL

    $49,582.42 · 54 txns

  5. 5

    ESTHER HAN

    $42,474.89 · 51 txns

Summary Comparison

Metric Haemonetics Corporation Axonics, Inc.
Total Payments $3.7M $3.7M
% of Industry Total 0.0% 0.0%
Transaction Count 2,104 21,364
Avg per Transaction $1.8K $174.18
Recipient Count 1,963 21,250
Avg per Recipient $1.9K $175.12
Payment Type Count 9 7
Top Payment Type Acquisitions Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.